SCHEMBL28890958

SCHEMBL28890958

CCOC(=O)c1cnc(SC)nc1NCc1ccc(OC)cc1Cl

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.58
▸ MAPT P10636 7/20 0.56
▸ LMNA P02545 3/20 0.54
▸ SYK P43405 2/20 0.52
▸ HTT P42858 2/20 0.51
▸ MAPK1 P28482 1/20 0.51
▸ HPGD P15428 4/20 0.49
▸ TDP1 Q9NUW8 4/20 0.49
▸ SMN1; SMN2 Q16637 3/20 0.49
▸ FOS P01100 1/20 0.47
▸ JUN P05412 1/20 0.47
▸ NFKB1 P19838 1/20 0.47
▸ NFKB2 Q00653 1/20 0.47
▸ RELA Q04206 1/20 0.47
▸ TP53 P04637 1/20 0.46
▸ KMT2A Q03164 2/20 0.46
▸ NPSR1 Q6W5P4 1/20 0.46
▸ POLB P06746 2/20 0.45
▸ MEN1 O00255 1/20 0.44
▸ KDM4E B2RXH2 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13780291 0.89 TDP1 (0.62) ALDH1A1MAPTLMNASYKHTT
SCHEMBL4712695 0.84 ALDH1A1 (0.65) ALDH1A1MAPTLMNASYKHTT
SCHEMBL17013474 0.83 ALDH1A1 (0.56) ALDH1A1MAPTLMNASYKHTT
SCHEMBL28415492 0.82 ALDH1A1 (0.61) ALDH1A1MAPTLMNASYKHTT
SCHEMBL31694381 0.81 PDE5A (0.59) ALDH1A1MAPTSYKHTTMAPK1
SCHEMBL1679801 0.81 PDE5A (0.59) ALDH1A1MAPTSYKHTTMAPK1
SCHEMBL29972749 0.81 PDE5A (0.59) ALDH1A1MAPTSYKHTTMAPK1
SCHEMBL16816475 0.81 ALDH1A1 (0.60) ALDH1A1MAPTLMNASYKHTT
SCHEMBL13780325 0.78 HTT (0.50) ALDH1A1MAPTLMNAHTTHPGD
SCHEMBL17013486 0.78 ALDH1A1 (0.59) ALDH1A1MAPTLMNASYKHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111297868-A Use of a composition comprising a heterocyclic compound for the manufacture of a medicament for the treatment of phosphodiesterase mediated diseases 黄泳华 2020-06-19 — — CN claimed
CN-111297868-A Use of a composition comprising a heterocyclic compound for the manufacture of a medicament for the treatment of phosphodiesterase mediated diseases 黄泳华 2020-06-19 — — CN disclosed
Send feedback